FHIL - ETF AI Analysis
Top Page
Federated Hermes International Leaders ETF (FHIL)
FHIL, the Federated Hermes International Leaders ETF, has a solid overall rating driven mainly by high-quality global leaders like TSMC and ASML, which benefit from strong financial performance and key roles in advanced technology and AI. Financial giants such as Mitsubishi UFJ, Sumitomo Mitsui, and UniCredit also support the fund’s quality through solid profitability and generally positive outlooks, though some face leverage, cash flow, or bearish technical trends. Weaker spots like Nokia and Air Liquide, where valuation concerns, margin pressures, or bearish price trends appear, slightly hold back the rating, and investors should note the fund’s meaningful exposure to financial and technology-related names as a key risk factor.
FHIL vs. SPDR S&P 500 ETF (SPY)
- AUM
- 3.53M
- Region
- Developed Markets
- Expense Ratio
- 0.48%
- Beta
- 0.68
- Issuer
- Federated Hermes
- Inception Date
- Jun 17, 2026
- Dividend Yield
- N/A
- Asset Class
- Equity
- Index Tracked
- No Underlying Index
FHIL Summary
FHIL (Federated Hermes International Leaders ETF) is an actively managed fund that focuses on international stocks, mainly outside the U.S., with a tilt toward companies the managers believe are undervalued. It doesn’t track a fixed index, but instead looks across many countries and sectors for long-term growth opportunities. The fund holds well-known names like TSMC and ASML, giving investors exposure to leading global businesses and added diversification beyond the U.S. market. A key risk is that international and value-focused stocks can be volatile and may underperform U.S. or growth stocks for long periods, so the share price can move up and down significantly.
How much will it cost me?
This ETF has an expense ratio of 0.48%, which means you’ll pay about $4.80 per year for every $1,000 you invest. That’s higher than the average low-cost index ETF because this fund is actively managed, with managers researching and selecting stocks rather than just tracking an index.
What would affect this ETF?
This ETF could benefit if international economies outside the U.S. strengthen, especially in sectors like financials, technology, and health care, and if value-style stocks come back into favor, helping holdings such as AstraZeneca, ASML, TSMC, and HSBC. On the other hand, global slowdowns, rising interest rates that hurt banks and other financials, regulatory changes affecting big tech and health care companies, or country-specific issues in developed markets could weigh on performance.
FHIL Top 10 Holdings
FHIL is leaning heavily on global semiconductors, with ASML and TSMC acting as the fund’s main engines—both have been rising this year and give the portfolio a clear tech‑hardware tilt. Financials are the other big storyline: Japanese banks like Mitsubishi UFJ and Sumitomo Mitsui have been steady to rising, quietly supporting returns, while UniCredit adds a more mixed European flavor. On the flip side, AstraZeneca and Sony have been lagging, sapping some momentum. Overall, it’s a developed‑markets, ex‑U.S. mix with a clear bias toward chipmakers and banks.
| Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
 AZN | AstraZeneca | ― | ― | ― | ― | 80Outperform |
 NL:ASML | ASML Holding NV | 2.86% | $102.46K | EUR 574.81B | 63.67% | 76Outperform |
 SONY | Sony Group | 2.57% | $92.28K | $148.23B | -9.62% | 75Outperform |
 TSM | TSMC | 2.41% | $86.36K | $1.92T | 41.54% | 81Outperform |
 MUFG | Mitsubishi UFJ | 2.30% | $82.58K | $247.80B | 46.27% | 77Outperform |
 SMFG | Sumitomo Mitsui | 2.13% | $76.50K | $156.31B | 52.69% | 76Outperform |
 GB:SSE | SSE | 2.14% | $76.89K | GBP 32.14B | 39.32% | 74Outperform |
FHIL Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For FHIL, the sentiment is Positive. The current price of 23.67 is above the 20-day moving average (MA) of 23.48, below the 50-day MA of 24.12, and compared to the 200-day MA of , indicating a neutral trend. The MACD of -0.23 indicates Negative momentum. The RSI at 51.19 is Neutral, neither overbought nor oversold. The STOCH value of 92.32 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for FHIL.
FHIL Peer Comparison
Comparison Results
| Name | Price | Price Target | AUM | Expense Ratio | Overall Rating |
|---|---|---|---|---|---|
| FHIL | $23.67 | $26.00(9.85% Upside) | $3.53M | 0.48% | 62Neutral |
 INEQ | $39.41 | $47.16(19.67% Upside) | $92.08M | 0.45% | 66Neutral |
 IQGR | $24.66 | $30.55(23.89% Upside) | $24.13M | 0.58% | 60Neutral |
 RWIN | $27.47 | $32.71(19.05% Upside) | $20.39M | 0.42% | 66Neutral |
 LCIV | $25.93 | ― | $20.14M | 0.99% | 67Neutral |
 HWIV | $26.34 | $36.36(38.05% Upside) | $1.57M | 0.70% | 62Neutral |
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| FHIL | Federated Hermes International Leaders ETF | 23.67 | -1.32 | -5.27% | |
| INEQ | Columbia International Equity Income Etf | 39.41 | 5.22 | 15.26% | |
| IQGR | Astoria International Quality Growth Kings ETF | 24.66 | -0.31 | -1.25% | |
| RWIN | Rayliant NxtGen Multifactor International Equity ETF | 27.47 | 1.75 | 6.81% | |
| LCIV | Logan Capital International ETF | 25.93 | 1.10 | 4.44% | |
| HWIV | Hotchkis & Wiley International Value Fund ETF | 26.34 | 0.89 | 3.48% |
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.